Cancer News Genetics May Predict Bladder Cancer Immunotherapy Response Science Daily
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Cancer News Genetics May Predict Bladder Cancer Immunotherapy Response Science Daily is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
How colorectal cancer evades immunotherapy using a dual barrier
Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the ... Read More
A hormone that silences the immune system may unlock new cancer treatments
Scientists have discovered that cancer uses a hidden hormone to switch off the body’s natural defenses, allowing tumors to grow unchecked. By uncovering this secret signal, they found a way to block ... Read More
Scientists just cracked the mystery of why cancer immunotherapy fails
Ohio State researchers have discovered that exhausted T cells collapse under the weight of misfolded proteins, activating a destructive stress response called TexPSR. Unlike normal stress systems, ... Read More
The hidden “Big Bang” that decides how bowel cancer grows
Scientists have pinpointed a “Big Bang” moment in bowel cancer—when cells first evade the immune system. This early immune escape locks in how the cancer will behave as it grows. The discovery could h ... Read More
COVID mRNA Vaccines Enhance Cancer Immunotherapy: Now What?
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology. Read More
The Cancer Immunotherapy Revolution: From Artificial Sweeteners to T-Cell Monitoring
Immune checkpoint inhibitors, popularized by Allison and Honjo’s Nobel Prize, were one of the first cancer immunotherapies that gained FDA approval. In the 1990s, Allison and Honjo identified the ... Read More
Colorectal cancer evades immunotherapy using a dual barrier
A study by IRB Barcelona and CNAG reveals how metastatic colorectal tumours block the immune system through two complementary mechanisms. Published in Nature Genetics, the work identifies a key ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus